Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Canadian Agency for Drugs and Technologies in Health (CADTH). Transcranial magnetic stimulation for the treatment of adults with PTSD, GAD, or depression: a review of clinical effectiveness and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary with Critical Appraisal. 2014 Authors' conclusions There is early evidence in the form of two systematic reviews and one RCT that TMS may offer improved clinical outcomes for patients with PTSD. There were no primary research studies found in the systematic review assessing the use of rTMS for treating patients with GAD. Four HTAs indicate that while evidence tends to demonstrate the effectiveness of rTMS, it is insufficient to draw conclusions regarding the use of TMS for treating patients with depression; additional systematic reviews and meta-analyses for the use of TMS for treating depression have also reported benefits. Five guideline documents include recommendations regarding the use of TMS in practice, but are variable between organizations. Indexing Status Subject indexing assigned by CRD MeSH Anxiety; Anxiety Disorders; Combat Disorders; Depression; Depressive Disorder; Panic Disorder; Postpartum; Shell Shock; Transcranial Magnetic Stimulations Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32015000829 Date abstract record published 30/06/2015 |